Page last updated: 2024-11-02

pentobarbital and Metabolic Diseases

pentobarbital has been researched along with Metabolic Diseases in 2 studies

Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.

Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bullock, JD1
Albert, DM1
Davidson, MB1

Other Studies

2 other studies available for pentobarbital and Metabolic Diseases

ArticleYear
Generalized oxalosis with retinal involvement following methoxyflurane anesthesia.
    Anesthesiology, 1974, Volume: 41, Issue:3

    Topics: Acute Kidney Injury; Anesthesia, General; Biopsy; Calcium; Humans; Kidney; Male; Metabolic Diseases;

1974
Studies on the mechanism of pentobarbital-induced glucose intolerance.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1971, Volume: 3, Issue:4

    Topics: Adipose Tissue; Animals; Blood Glucose; Carbon Dioxide; Carbon Isotopes; Depression, Chemical; Diaph

1971